1. Home
  2. BCRX vs LASR Comparison

BCRX vs LASR Comparison

Compare BCRX & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

N/A

Current Price

$8.51

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Logo nLIGHT Inc.

LASR

nLIGHT Inc.

N/A

Current Price

$66.66

Market Cap

2.3B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
BCRX
LASR
Founded
1986
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
BCRX
LASR
Price
$8.51
$66.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
8
Target Price
$20.82
$50.56
AVG Volume (30 Days)
4.2M
1.8M
Earning Date
05-15-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
381.40
62.99
EPS
1.21
N/A
Revenue
$25,186,000.00
$191,359,000.00
Revenue This Year
N/A
$9.24
Revenue Next Year
$12.55
$13.99
P/E Ratio
$7.23
N/A
Revenue Growth
N/A
38.09
52 Week Low
$6.00
$6.20
52 Week High
$11.31
$69.52

Technical Indicators

Market Signals
Indicator
BCRX
LASR
Relative Strength Index (RSI) 63.78 61.22
Support Level $7.95 $27.61
Resistance Level $8.68 $69.52
Average True Range (ATR) 0.31 5.03
MACD 0.05 0.02
Stochastic Oscillator 70.43 75.05

Price Performance

Historical Comparison
BCRX
LASR

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.

Share on Social Networks: